Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2017 | Pages:
119 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Notes: Sales, means the sales volume of Sulphonamides Revenue, means the sales value of Sulphonamides This report studies sales (consumption) of Sulphonamides in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering • Abbott Laboratories • Boehringer Ingelheim Pharmaceuticals • Bayer AG • GlaxoSmithKline • King Pharmaceuticals • Mylan Pharmaceuticals • Novartis International AG • Pfizer • Par Pharmaceutical • Roche Holding AG • Sanofi Aventis • Stiefel Laboratories Market Segment by States, covering • California • Texas • New York • Florida • Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into • Orally Absorbable Sulfonamide • Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) • Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Split by applications, this report focuses on sales, market share and growth rate of Sulphonamides in each application, can be divided into • Skin Infections • Gastro Intestinal Tract (GIT) Infection • Meningitis
Table of Contents
United States Sulphonamides Market Report 2017
1 Sulphonamides Overview
1.1 Product Overview and Scope of Sulphonamides
1.2 Classification of Sulphonamides
1.2.1 Orally Absorbable Sulfonamide
1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.3 Application of Sulphonamides
1.3.1 Skin Infections
1.3.2 Gastro Intestinal Tract (GIT) Infection
1.3.3 Meningitis
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Sulphonamides (2012-2022)
1.4.1 United States Sulphonamides Sales and Growth Rate (2012-2022)
1.4.2 United States Sulphonamides Revenue and Growth Rate (2012-2022)
2 United States Sulphonamides Competition by Manufacturers
2.1 United States Sulphonamides Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Sulphonamides Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Sulphonamides Average Price by Manufactures (2015 and 2016)
2.4 Sulphonamides Market Competitive Situation and Trends
2.4.1 Sulphonamides Market Concentration Rate
2.4.2 Sulphonamides Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Sulphonamides Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Sulphonamides Sales and Market Share by States (2012-2017)
3.2 United States Sulphonamides Revenue and Market Share by States (2012-2017)
3.3 United States Sulphonamides Price by States (2012-2017)
4 United States Sulphonamides Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Sulphonamides Sales and Market Share by Type (2012-2017)
4.2 United States Sulphonamides Revenue and Market Share by Type (2012-2017)
4.3 United States Sulphonamides Price by Type (2012-2017)
4.4 United States Sulphonamides Sales Growth Rate by Type (2012-2017)
5 United States Sulphonamides Sales (Volume) by Application (2012-2017)
5.1 United States Sulphonamides Sales and Market Share by Application (2012-2017)
5.2 United States Sulphonamides Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Sulphonamides Manufacturers Profiles/Analysis
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Sulphonamides Product Type, Application and Specification
6.1.2.1 Orally Absorbable Sulfonamide
6.1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.1.3 Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim Pharmaceuticals
6.2.2 Sulphonamides Product Type, Application and Specification
6.2.2.1 Orally Absorbable Sulfonamide
6.2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bayer AG
6.3.2 Sulphonamides Product Type, Application and Specification
6.3.2.1 Orally Absorbable Sulfonamide
6.3.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.3.3 Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Sulphonamides Product Type, Application and Specification
6.4.2.1 Orally Absorbable Sulfonamide
6.4.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 King Pharmaceuticals
6.5.2 Sulphonamides Product Type, Application and Specification
6.5.2.1 Orally Absorbable Sulfonamide
6.5.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Mylan Pharmaceuticals
6.6.2 Sulphonamides Product Type, Application and Specification
6.6.2.1 Orally Absorbable Sulfonamide
6.6.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis International AG
6.7.2 Sulphonamides Product Type, Application and Specification
6.7.2.1 Orally Absorbable Sulfonamide
6.7.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.7.3 Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Sulphonamides Product Type, Application and Specification
6.8.2.1 Orally Absorbable Sulfonamide
6.8.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.8.3 Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Par Pharmaceutical
6.9.2 Sulphonamides Product Type, Application and Specification
6.9.2.1 Orally Absorbable Sulfonamide
6.9.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Roche Holding AG
6.10.2 Sulphonamides Product Type, Application and Specification
6.10.2.1 Orally Absorbable Sulfonamide
6.10.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
6.10.3 Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Sanofi Aventis
6.12 Stiefel Laboratories
7 Sulphonamides Manufacturing Cost Analysis
7.1 Sulphonamides Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sulphonamides
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Sulphonamides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Sulphonamides Market Forecast (2017-2022)
11.1 United States Sulphonamides Sales, Revenue Forecast (2017-2022)
11.2 United States Sulphonamides Sales Forecast by Type (2017-2022)
11.3 United States Sulphonamides Sales Forecast by Application (2017-2022)
11.4 Sulphonamides Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Sulphonamides
Table Classification of Sulphonamides
Figure United States Sales Market Share of Sulphonamides by Type in 2015
Figure Orally Absorbable Sulfonamide Picture
Figure Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Picture
Figure Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Picture
Table Application of Sulphonamides
Figure United States Sales Market Share of Sulphonamides by Application in 2015
Figure Skin Infections Examples
Figure Gastro Intestinal Tract (GIT) Infection Examples
Figure Meningitis Examples
Figure United States Sulphonamides Sales and Growth Rate (2012-2022)
Figure United States Sulphonamides Revenue and Growth Rate (2012-2022)
Table United States Sulphonamides Sales of Key Manufacturers (2015 and 2016)
Table United States Sulphonamides Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Sulphonamides Sales Share by Manufacturers
Figure 2016 Sulphonamides Sales Share by Manufacturers
Table United States Sulphonamides Revenue by Manufacturers (2015 and 2016)
Table United States Sulphonamides Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Sulphonamides Revenue Share by Manufacturers
Table 2016 United States Sulphonamides Revenue Share by Manufacturers
Table United States Market Sulphonamides Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Sulphonamides Average Price of Key Manufacturers in 2015
Figure Sulphonamides Market Share of Top 3 Manufacturers
Figure Sulphonamides Market Share of Top 5 Manufacturers
Table United States Sulphonamides Sales by States (2012-2017)
Table United States Sulphonamides Sales Share by States (2012-2017)
Figure United States Sulphonamides Sales Market Share by States in 2015
Table United States Sulphonamides Revenue and Market Share by States (2012-2017)
Table United States Sulphonamides Revenue Share by States (2012-2017)
Figure Revenue Market Share of Sulphonamides by States (2012-2017)
Table United States Sulphonamides Price by States (2012-2017)
Table United States Sulphonamides Sales by Type (2012-2017)
Table United States Sulphonamides Sales Share by Type (2012-2017)
Figure United States Sulphonamides Sales Market Share by Type in 2015
Table United States Sulphonamides Revenue and Market Share by Type (2012-2017)
Table United States Sulphonamides Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sulphonamides by Type (2012-2017)
Table United States Sulphonamides Price by Type (2012-2017)
Figure United States Sulphonamides Sales Growth Rate by Type (2012-2017)
Table United States Sulphonamides Sales by Application (2012-2017)
Table United States Sulphonamides Sales Market Share by Application (2012-2017)
Figure United States Sulphonamides Sales Market Share by Application in 2015
Table United States Sulphonamides Sales Growth Rate by Application (2012-2017)
Figure United States Sulphonamides Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Sulphonamides Sales Market Share (2012-2017)
Table Boehringer Ingelheim Pharmaceuticals Basic Information List
Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Sulphonamides Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Sulphonamides Sales Market Share (2012-2017)
Table King Pharmaceuticals Basic Information List
Table King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table King Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)
Table Mylan Pharmaceuticals Basic Information List
Table Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)
Table Novartis International AG Basic Information List
Table Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis International AG Sulphonamides Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Sulphonamides Sales Market Share (2012-2017)
Table Par Pharmaceutical Basic Information List
Table Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Par Pharmaceutical Sulphonamides Sales Market Share (2012-2017)
Table Roche Holding AG Basic Information List
Table Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Holding AG Sulphonamides Sales Market Share (2012-2017)
Table Sanofi Aventis Basic Information List
Table Stiefel Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sulphonamides
Figure Manufacturing Process Analysis of Sulphonamides
Figure Sulphonamides Industrial Chain Analysis
Table Raw Materials Sources of Sulphonamides Major Manufacturers in 2015
Table Major Buyers of Sulphonamides
Table Distributors/Traders List
Figure United States Sulphonamides Production and Growth Rate Forecast (2017-2022)
Figure United States Sulphonamides Revenue and Growth Rate Forecast (2017-2022)
Table United States Sulphonamides Production Forecast by Type (2017-2022)
Table United States Sulphonamides Consumption Forecast by Application (2017-2022)
Table United States Sulphonamides Sales Forecast by States (2017-2022)
Table United States Sulphonamides Sales Share Forecast by States (2017-2022) 
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
